Birth control patch warning to include risk of blood clots
The Ortho Evra birth control patch warning label was recently updated to indicate that it carries an increased risk of blood clots when compared with traditional birth control pills. This warning, which was announced on September 20, is long overdue.
Saiontz, Kirk & Miles has been investigating Ortho Evra side effects claims over a year. We filed a birth control patch lawsuit in the U.S. Federal District Court of Maryland for one of our clients in January 2006, alleging that the manufacturer failed to adequately warn physicians and consumers of the increased risk of developing blood clots, pulmonary embolism, stroke, heart attack and/or deep vein thrombosis.
This new warning for the birth control patch comes nearly one year after the an FDA ordered label update in November 2005 alerting women that using the patch exposes them to about 60% more estrogen than using birth control pulls. The FDA has requested additional studies continue for at least 18 months to two years.? These studies will include nearly 500,000 women.?
Experts across the country have called for Ortho Evra birth control patch to be removed from the market, feeling that the additional warnings are still insufficient and that the benefits of the patch do not justify the significant risk it poses.
New claims for injuries suffered by users of the Ortho Evra birth control patch are being reviewed and investigated by our product liability lawyers.? If you, a friend or family member have suffered a blood clot, deep vein thrombosis, pulmonary embolism, stroke or heart attack after using the patch, request a free consultation and claim evaluation.
